[Novel treatment for chronic hepatitis C in near future].
Showa University Fujigaoka Hospital, Japan. kazuaki-inoue@showa-university-fujigaoka.gr.jp
Kazuaki
K
Inoue
Tsunamasa
T
Watanabe
Masaya
M
Yamada
Shinsho
S
Yoshiba
D016503:Drug Delivery Systems; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D009842:Oligopeptides / Q000627:therapeutic use; D011392:Proline / Q000031:analogs & derivatives / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use
D009842:Oligopeptides; D011480:Protease Inhibitors; C486464:telaprevir; C512204:N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide; D011392:Proline